Tom Schaberg

3.3k total citations
35 papers, 1.6k citations indexed

About

Tom Schaberg is a scholar working on Epidemiology, Infectious Diseases and Surgery. According to data from OpenAlex, Tom Schaberg has authored 35 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 16 papers in Infectious Diseases and 8 papers in Surgery. Recurrent topics in Tom Schaberg's work include Tuberculosis Research and Epidemiology (16 papers), Pneumonia and Respiratory Infections (9 papers) and Pneumocystis jirovecii pneumonia detection and treatment (8 papers). Tom Schaberg is often cited by papers focused on Tuberculosis Research and Epidemiology (16 papers), Pneumonia and Respiratory Infections (9 papers) and Pneumocystis jirovecii pneumonia detection and treatment (8 papers). Tom Schaberg collaborates with scholars based in Germany, United States and Italy. Tom Schaberg's co-authors include H. Lode, Harald Mauch, J Eller, Michael S. Niederman, R Erbes, R. Loddenkemper, Roland Diel, Christoph Lange, Torsten Bauer and Mathias W. Pletz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Biochemical and Biophysical Research Communications.

In The Last Decade

Tom Schaberg

34 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tom Schaberg Germany 19 797 640 481 233 229 35 1.6k
Digamber Behera India 25 576 0.7× 642 1.0× 846 1.8× 292 1.3× 313 1.4× 93 1.6k
Graham Mills New Zealand 19 765 1.0× 506 0.8× 139 0.3× 195 0.8× 71 0.3× 36 1.5k
Menno M. van der Eerden Netherlands 20 794 1.0× 505 0.8× 266 0.6× 163 0.7× 44 0.2× 43 1.4k
A de Roux Germany 19 1.2k 1.6× 425 0.7× 402 0.8× 43 0.2× 116 0.5× 35 1.8k
Kosaku Komiya Japan 17 404 0.5× 358 0.6× 254 0.5× 155 0.7× 264 1.2× 115 1.1k
Shannon Novosad United States 15 569 0.7× 177 0.3× 430 0.9× 75 0.3× 149 0.7× 36 1.2k
Russell J. McCulloh United States 22 726 0.9× 265 0.4× 162 0.3× 104 0.4× 110 0.5× 84 1.6k
Karen M. Starko United States 13 305 0.4× 1.5k 2.4× 171 0.4× 564 2.4× 164 0.7× 16 2.2k
Ivan Le Jeune United Kingdom 11 1.0k 1.3× 973 1.5× 137 0.3× 412 1.8× 99 0.4× 17 2.1k
Doosoo Jeon South Korea 19 611 0.8× 222 0.3× 590 1.2× 72 0.3× 386 1.7× 109 1.2k

Countries citing papers authored by Tom Schaberg

Since Specialization
Citations

This map shows the geographic impact of Tom Schaberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Schaberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Schaberg more than expected).

Fields of papers citing papers by Tom Schaberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Schaberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Schaberg. The network helps show where Tom Schaberg may publish in the future.

Co-authorship network of co-authors of Tom Schaberg

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Schaberg. A scholar is included among the top collaborators of Tom Schaberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Schaberg. Tom Schaberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lange, Christoph, et al.. (2025). Update: Therapie der medikamentenresistenten Tuberkulose (DR-TB) in Deutschland, Österreich und der Schweiz. Pneumologie. 80(3). 160–167. 1 indexed citations
2.
Otto-Knapp, Ralf, Torsten T. Bauer, Folke Brinkmann, et al.. (2024). Treatment of MDR, Pre-XDR, XDR, and Rifampicin-Resistant Tuberculosis or in Case of Intolerance to at Least Rifampicin in Austria, Germany, and Switzerland. Respiration. 103(9). 593–600. 1 indexed citations
3.
Nealon, Joshua, Tor Biering‐Sørensen, Pascal Crépey, et al.. (2024). Influenza vaccine effectiveness in older adults: study methods, transparency and impacts on public health. International Journal of Infectious Diseases. 145. 107103–107103. 1 indexed citations
4.
Herzmann, Christian, Martin Ernst, Christoph Lange, et al.. (2017). Pulmonary immune responses to Mycobacterium tuberculosis in exposed individuals. PLoS ONE. 12(11). e0187882–e0187882. 10 indexed citations
5.
Herzmann, Christian, Giovanni Sotgiu, Roland Diel, et al.. (2016). Risk for latent and active tuberculosis in Germany. Infection. 45(3). 283–290. 23 indexed citations
6.
Dara, Masoud, Ivan Solovič, Giovanni Sotgiu, et al.. (2016). Tuberculosis care among refugees arriving in Europe: a ERS/WHO Europe Region survey of current practices. European Respiratory Journal. 48(3). 808–817. 53 indexed citations
7.
Pletz, Mathias W., et al.. (2016). Antiviral Medications in Seasonal and Pandemic Influenza. Deutsches Ärzteblatt international. 113(47). 799–807. 25 indexed citations
8.
Diel, Roland, et al.. (2012). Tuberculosis: cost of illness in Germany. European Respiratory Journal. 40(1). 143–151. 62 indexed citations
9.
Ewig, Santiago, Mathias W. Pletz, Gernot Rohde, et al.. (2011). Community-acquired pneumonia in younger patients is an entity on its own. European Respiratory Journal. 39(5). 1156–1161. 47 indexed citations
10.
Ewig, Santiago, Mathias W. Pletz, Gernot Rohde, et al.. (2011). Nursing-home-acquired pneumonia in Germany: an 8-year prospective multicentre study. Thorax. 67(2). 132–138. 85 indexed citations
11.
Schoefer, Yvonne, et al.. (2007). Determinants of influenza and pneumococcal vaccination in patients with chronic lung diseases. Journal of Infection. 55(4). 347–352. 27 indexed citations
12.
Diel, Roland, et al.. (2004). The cost structure of lung tuberculosis in Germany. The European Journal of Health Economics. 5(3). 243–251. 10 indexed citations
13.
Wilson, Robert, L. Allegra, Gérard Huchon, et al.. (2004). Short-term and Long-term Outcomes of Moxifloxacin Compared to Standard Antibiotic Treatment in Acute Exacerbations of Chronic Bronchitis. CHEST Journal. 125(3). 953–964. 149 indexed citations
14.
Munk, Martin E., et al.. (1999). Phenotypically Activated γδ T Lymphocytes in the Peripheral Blood of Patients with Tuberculosis. The Journal of Infectious Diseases. 180(1). 141–149. 28 indexed citations
15.
Eller, J, et al.. (1998). Infective Exacerbations of Chronic Bronchitis. CHEST Journal. 113(6). 1542–1548. 277 indexed citations
16.
Lode, H., Tom Schaberg, M. Raffenberg, & Harald Mauch. (1998). NOSOCOMIAL PNEUMONIA IN THE CRITICAL CARE UNIT. Critical Care Clinics. 14(1). 119–133. 12 indexed citations
17.
Worth, H., Dieter Adam, Werner Handrick, et al.. (1997). Prophylaxe und Therapie von bronchialen Infektionen: Empfehlungen der Deutschen Atemwegsliga in der Deutschen Gesellschaft für Pneumologie. Medizinische Klinik - Intensivmedizin und Notfallmedizin. 92(12). 699–704. 3 indexed citations
18.
Erbes, R, Tom Schaberg, & R. Loddenkemper. (1997). Lung Function Tests in Patients With Idiopathic Pulmonary Fibrosis. CHEST Journal. 111(1). 51–57. 135 indexed citations
19.
20.
Schaberg, Tom, Hermann Haller, & H. Lode. (1991). Evidence for a platelet-activating factor receptor on human alveolar macrophages. Biochemical and Biophysical Research Communications. 177(2). 704–710. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Digamber Behera Breakdown of academic impact, for papers by Graham Mills Breakdown of academic impact, for papers by Menno M. van der Eerden Breakdown of academic impact, for papers by A de Roux Breakdown of academic impact, for papers by Kosaku Komiya Breakdown of academic impact, for papers by Shannon Novosad Breakdown of academic impact, for papers by Russell J. McCulloh Breakdown of academic impact, for papers by Karen M. Starko Breakdown of academic impact, for papers by Ivan Le Jeune Breakdown of academic impact, for papers by Doosoo Jeon
Rankless by CCL
2026